[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

Fibrate Drugs Market - Global Outlook and Forecast 2021-2027

April 2021 | 92 pages | ID: F8279B4966C9EN
Market Monitor Global

US$ 3,250.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
This report contains market size and forecasts of Fibrate Drugs in Global, including the following market information:

Global Fibrate Drugs Market Revenue, 2016-2021, 2022-2027, ($ millions)

Global top five companies in 2020 (%)

The global Fibrate Drugs market was valued at xx million in 2020 and is projected to reach US$ xx million by 2027, at a CAGR of xx% during the forecast period.

MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Fibrate Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global Fibrate Drugs Market, By Type, 2016-2021, 2022-2027 ($ millions)

Global Fibrate Drugs Market Segment Percentages, By Type, 2020 (%)
  • Lofibrate
  • Fenofibrates
  • Fenofibric Acids
  • Gemfibrozil
China Fibrate Drugs Market, By Application, 2016-2021, 2022-2027 ($ millions)

China Fibrate Drugs Market Segment Percentages, By Application, 2020 (%)
  • Hospitals Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
Global Fibrate Drugs Market, By Region and Country, 2016-2021, 2022-2027 ($ Millions)

Global Fibrate Drugs Market Segment Percentages, By Region and Country, 2020 (%)
  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • France
    • U.K.
    • Italy
    • Russia
    • Nordic Countries
    • Benelux
    • Rest of Europe
  • Asia
    • China
    • Japan
    • South Korea
    • Southeast Asia
    • India
    • Rest of Asia
  • South America
    • Brazil
    • Argentina
    • Rest of South America
  • Middle East & Africa
    • Turkey
    • Israel
    • Saudi Arabia
    • UAE
    • Rest of Middle East & Africa
Competitor Analysis

The report also provides analysis of leading market participants including:

Total Fibrate Drugs Market Competitors Revenues in Global, by Players 2016-2021 (Estimated), ($ millions)

Total Fibrate Drugs Market Competitors Revenues Share in Global, by Players 2020 (%)

Further, the report presents profiles of competitors in the market, including the following:
  • Teva Pharmaceutical Industries
  • Pfizer, Inc.
  • Mylan N.V.
  • Sanofi SA
  • Novartis AG
  • GlaxoSmithKline plc
  • Sun Pharmaceutical Industries, Inc.
  • Macleods Pharmaceuticals Limited
  • Aurobindo Pharma
  • Abbott
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS

1.1 Fibrate Drugs Market Definition
1.2 Market Segments
  1.2.1 Market by Type
  1.2.2 Market by Application
1.3 Global Fibrate Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
  1.5.1 Research Methodology
  1.5.2 Research Process
  1.5.3 Base Year
  1.5.4 Report Assumptions & Caveats

2 GLOBAL FIBRATE DRUGS OVERALL MARKET SIZE

2.1 Global Fibrate Drugs Market Size: 2021 VS 2027
2.2 Global Fibrate Drugs Market Size, Prospects & Forecasts: 2016-2027
2.3 Key Market Trends, Opportunity, Drivers and Restraints
  2.3.1 Market Opportunities & Trends
  2.3.2 Market Drivers
  2.3.3 Market Restraints

3 COMPANY LANDSCAPE

3.1 Top Fibrate Drugs Players in Global Market
3.2 Top Global Fibrate Drugs Companies Ranked by Revenue
3.3 Global Fibrate Drugs Revenue by Companies
3.4 Top 3 and Top 5 Fibrate Drugs Companies in Global Market, by Revenue in 2020
3.5 Global Companies Fibrate Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Fibrate Drugs Players in Global Market
  3.6.1 List of Global Tier 1 Fibrate Drugs Companies
  3.6.2 List of Global Tier 2 and Tier 3 Fibrate Drugs Companies

4 MARKET SIGHTS BY PRODUCT

4.1 Overview
  4.1.1 By Type - Global Fibrate Drugs Market Size Markets, 2021 & 2027
  4.1.2 Lofibrate
  4.1.3 Fenofibrates
  4.1.4 Fenofibric Acids
  4.1.5 Gemfibrozil
4.2 By Type - Global Fibrate Drugs Revenue & Forecasts
  4.2.1 By Type - Global Fibrate Drugs Revenue, 2016-2021
  4.2.2 By Type - Global Fibrate Drugs Revenue, 2022-2027
  4.2.3 By Type - Global Fibrate Drugs Revenue Market Share, 2016-2027

5 SIGHTS BY APPLICATION

5.1 Overview
  5.1.1 By Application - Global Fibrate Drugs Market Size, 2021 & 2027
  5.1.2 Hospitals Pharmacies
  5.1.3 Retail Pharmacies
  5.1.4 Online Pharmacies
5.2 By Application - Global Fibrate Drugs Revenue & Forecasts
  5.2.1 By Application - Global Fibrate Drugs Revenue, 2016-2021
  5.2.2 By Application - Global Fibrate Drugs Revenue, 2022-2027
  5.2.3 By Application - Global Fibrate Drugs Revenue Market Share, 2016-2027

6 SIGHTS BY REGION

6.1 By Region - Global Fibrate Drugs Market Size, 2021 & 2027
6.2 By Region - Global Fibrate Drugs Revenue & Forecasts
  6.2.1 By Region - Global Fibrate Drugs Revenue, 2016-2021
  6.2.2 By Region - Global Fibrate Drugs Revenue, 2022-2027
  6.2.3 By Region - Global Fibrate Drugs Revenue Market Share, 2016-2027
6.3 North America
  6.3.1 By Country - North America Fibrate Drugs Revenue, 2016-2027
  6.3.2 US Fibrate Drugs Market Size, 2016-2027
  6.3.3 Canada Fibrate Drugs Market Size, 2016-2027
  6.3.4 Mexico Fibrate Drugs Market Size, 2016-2027
6.4 Europe
  6.4.1 By Country - Europe Fibrate Drugs Revenue, 2016-2027
  6.4.2 Germany Fibrate Drugs Market Size, 2016-2027
  6.4.3 France Fibrate Drugs Market Size, 2016-2027
  6.4.4 U.K. Fibrate Drugs Market Size, 2016-2027
  6.4.5 Italy Fibrate Drugs Market Size, 2016-2027
  6.4.6 Russia Fibrate Drugs Market Size, 2016-2027
  6.4.7 Nordic Countries Fibrate Drugs Market Size, 2016-2027
  6.4.8 Benelux Fibrate Drugs Market Size, 2016-2027
6.5 Asia
  6.5.1 By Region - Asia Fibrate Drugs Revenue, 2016-2027
  6.5.2 China Fibrate Drugs Market Size, 2016-2027
  6.5.3 Japan Fibrate Drugs Market Size, 2016-2027
  6.5.4 South Korea Fibrate Drugs Market Size, 2016-2027
  6.5.5 Southeast Asia Fibrate Drugs Market Size, 2016-2027
  6.5.6 India Fibrate Drugs Market Size, 2016-2027
6.6 South America
  6.6.1 By Country - South America Fibrate Drugs Revenue, 2016-2027
  6.6.2 Brazil Fibrate Drugs Market Size, 2016-2027
  6.6.3 Argentina Fibrate Drugs Market Size, 2016-2027
6.7 Middle East & Africa
  6.7.1 By Country - Middle East & Africa Fibrate Drugs Revenue, 2016-2027
  6.7.2 Turkey Fibrate Drugs Market Size, 2016-2027
  6.7.3 Israel Fibrate Drugs Market Size, 2016-2027
  6.7.4 Saudi Arabia Fibrate Drugs Market Size, 2016-2027
  6.7.5 UAE Fibrate Drugs Market Size, 2016-2027

7 PLAYERS PROFILES

7.1 Teva Pharmaceutical Industries
  7.1.1 Teva Pharmaceutical Industries Corporate Summary
  7.1.2 Teva Pharmaceutical Industries Business Overview
  7.1.3 Teva Pharmaceutical Industries Fibrate Drugs Major Product Offerings
  7.1.4 Teva Pharmaceutical Industries Fibrate Drugs Revenue in Global (2016-2021)
  7.1.5 Teva Pharmaceutical Industries Key News
7.2 Pfizer, Inc.
  7.2.1 Pfizer, Inc. Corporate Summary
  7.2.2 Pfizer, Inc. Business Overview
  7.2.3 Pfizer, Inc. Fibrate Drugs Major Product Offerings
  7.2.4 Pfizer, Inc. Fibrate Drugs Revenue in Global (2016-2021)
  7.2.5 Pfizer, Inc. Key News
7.3 Mylan N.V.
  7.3.1 Mylan N.V. Corporate Summary
  7.3.2 Mylan N.V. Business Overview
  7.3.3 Mylan N.V. Fibrate Drugs Major Product Offerings
  7.3.4 Mylan N.V. Fibrate Drugs Revenue in Global (2016-2021)
  7.3.5 Mylan N.V. Key News
7.4 Sanofi SA
  7.4.1 Sanofi SA Corporate Summary
  7.4.2 Sanofi SA Business Overview
  7.4.3 Sanofi SA Fibrate Drugs Major Product Offerings
  7.4.4 Sanofi SA Fibrate Drugs Revenue in Global (2016-2021)
  7.4.5 Sanofi SA Key News
7.5 Novartis AG
  7.5.1 Novartis AG Corporate Summary
  7.5.2 Novartis AG Business Overview
  7.5.3 Novartis AG Fibrate Drugs Major Product Offerings
  7.5.4 Novartis AG Fibrate Drugs Revenue in Global (2016-2021)
  7.5.5 Novartis AG Key News
7.6 GlaxoSmithKline plc
  7.6.1 GlaxoSmithKline plc Corporate Summary
  7.6.2 GlaxoSmithKline plc Business Overview
  7.6.3 GlaxoSmithKline plc Fibrate Drugs Major Product Offerings
  7.6.4 GlaxoSmithKline plc Fibrate Drugs Revenue in Global (2016-2021)
  7.6.5 GlaxoSmithKline plc Key News
7.7 Sun Pharmaceutical Industries, Inc.
  7.7.1 Sun Pharmaceutical Industries, Inc. Corporate Summary
  7.7.2 Sun Pharmaceutical Industries, Inc. Business Overview
  7.7.3 Sun Pharmaceutical Industries, Inc. Fibrate Drugs Major Product Offerings
  7.4.4 Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue in Global (2016-2021)
  7.7.5 Sun Pharmaceutical Industries, Inc. Key News
7.8 Macleods Pharmaceuticals Limited
  7.8.1 Macleods Pharmaceuticals Limited Corporate Summary
  7.8.2 Macleods Pharmaceuticals Limited Business Overview
  7.8.3 Macleods Pharmaceuticals Limited Fibrate Drugs Major Product Offerings
  7.8.4 Macleods Pharmaceuticals Limited Fibrate Drugs Revenue in Global (2016-2021)
  7.8.5 Macleods Pharmaceuticals Limited Key News
7.9 Aurobindo Pharma
  7.9.1 Aurobindo Pharma Corporate Summary
  7.9.2 Aurobindo Pharma Business Overview
  7.9.3 Aurobindo Pharma Fibrate Drugs Major Product Offerings
  7.9.4 Aurobindo Pharma Fibrate Drugs Revenue in Global (2016-2021)
  7.9.5 Aurobindo Pharma Key News
7.10 Abbott
  7.10.1 Abbott Corporate Summary
  7.10.2 Abbott Business Overview
  7.10.3 Abbott Fibrate Drugs Major Product Offerings
  7.10.4 Abbott Fibrate Drugs Revenue in Global (2016-2021)
  7.10.5 Abbott Key News

8 CONCLUSION

9 APPENDIX

9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES

Table 1. Fibrate Drugs Market Opportunities & Trends in Global Market
Table 2. Fibrate Drugs Market Drivers in Global Market
Table 3. Fibrate Drugs Market Restraints in Global Market
Table 4. Key Players of Fibrate Drugs in Global Market
Table 5. Top Fibrate Drugs Players in Global Market, Ranking by Revenue (2019)
Table 6. Global Fibrate Drugs Revenue by Companies, (US$, Mn), 2016-2021
Table 7. Global Fibrate Drugs Revenue Share by Companies, 2016-2021
Table 8. Global Companies Fibrate Drugs Product Type
Table 9. List of Global Tier 1 Fibrate Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Fibrate Drugs Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. By Type – Global Fibrate Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 12. By Type - Fibrate Drugs Revenue in Global (US$, Mn), 2016-2021
Table 13. By Type - Fibrate Drugs Revenue in Global (US$, Mn), 2022-2027
Table 14. By Application – Global Fibrate Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 15. By Application - Fibrate Drugs Revenue in Global (US$, Mn), 2016-2021
Table 16. By Application - Fibrate Drugs Revenue in Global (US$, Mn), 2022-2027
Table 17. By Region – Global Fibrate Drugs Revenue, (US$, Mn), 2021 VS 2027
Table 18. By Region - Global Fibrate Drugs Revenue (US$, Mn), 2016-2021
Table 19. By Region - Global Fibrate Drugs Revenue (US$, Mn), 2022-2027
Table 20. By Country - North America Fibrate Drugs Revenue, (US$, Mn), 2016-2021
Table 21. By Country - North America Fibrate Drugs Revenue, (US$, Mn), 2022-2027
Table 22. By Country - Europe Fibrate Drugs Revenue, (US$, Mn), 2016-2021
Table 23. By Country - Europe Fibrate Drugs Revenue, (US$, Mn), 2022-2027
Table 24. By Region - Asia Fibrate Drugs Revenue, (US$, Mn), 2016-2021
Table 25. By Region - Asia Fibrate Drugs Revenue, (US$, Mn), 2022-2027
Table 26. By Country - South America Fibrate Drugs Revenue, (US$, Mn), 2016-2021
Table 27. By Country - South America Fibrate Drugs Revenue, (US$, Mn), 2022-2027
Table 28. By Country - Middle East & Africa Fibrate Drugs Revenue, (US$, Mn), 2016-2021
Table 29. By Country - Middle East & Africa Fibrate Drugs Revenue, (US$, Mn), 2022-2027
Table 30. Teva Pharmaceutical Industries Corporate Summary
Table 31. Teva Pharmaceutical Industries Fibrate Drugs Product Offerings
Table 32. Teva Pharmaceutical Industries Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 33. Pfizer, Inc. Corporate Summary
Table 34. Pfizer, Inc. Fibrate Drugs Product Offerings
Table 35. Pfizer, Inc. Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 36. Mylan N.V. Corporate Summary
Table 37. Mylan N.V. Fibrate Drugs Product Offerings
Table 38. Mylan N.V. Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 39. Sanofi SA Corporate Summary
Table 40. Sanofi SA Fibrate Drugs Product Offerings
Table 41. Sanofi SA Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 42. Novartis AG Corporate Summary
Table 43. Novartis AG Fibrate Drugs Product Offerings
Table 44. Novartis AG Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 45. GlaxoSmithKline plc Corporate Summary
Table 46. GlaxoSmithKline plc Fibrate Drugs Product Offerings
Table 47. GlaxoSmithKline plc Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 48. Sun Pharmaceutical Industries, Inc. Corporate Summary
Table 49. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Product Offerings
Table 50. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 51. Macleods Pharmaceuticals Limited Corporate Summary
Table 52. Macleods Pharmaceuticals Limited Fibrate Drugs Product Offerings
Table 53. Macleods Pharmaceuticals Limited Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 54. Aurobindo Pharma Corporate Summary
Table 55. Aurobindo Pharma Fibrate Drugs Product Offerings
Table 56. Aurobindo Pharma Fibrate Drugs Revenue (US$, Mn), (2016-2021)
Table 57. Abbott Corporate Summary
Table 58. Abbott Fibrate Drugs Product Offerings
Table 59. Abbott Fibrate Drugs Revenue (US$, Mn), (2016-2021)

LIST OF FIGURES

Figure 1. Fibrate Drugs Segment by Type
Figure 2. Fibrate Drugs Segment by Application
Figure 3. Global Fibrate Drugs Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Fibrate Drugs Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. Global Fibrate Drugs Revenue, 2016-2027 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Fibrate Drugs Revenue in 2020
Figure 8. By Type - Global Fibrate Drugs Revenue Market Share, 2016-2027
Figure 9. By Application - Global Fibrate Drugs Revenue Market Share, 2016-2027
Figure 10. By Region - Global Fibrate Drugs Revenue Market Share, 2016-2027
Figure 11. By Country - North America Fibrate Drugs Revenue Market Share, 2016-2027
Figure 12. US Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 13. Canada Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 14. Mexico Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 15. By Country - Europe Fibrate Drugs Revenue Market Share, 2016-2027
Figure 16. Germany Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 17. France Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 18. U.K. Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 19. Italy Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 20. Russia Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 21. Nordic Countries Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 22. Benelux Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 23. By Region - Asia Fibrate Drugs Revenue Market Share, 2016-2027
Figure 24. China Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 25. Japan Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 26. South Korea Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 27. Southeast Asia Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 28. India Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 29. By Country - South America Fibrate Drugs Revenue Market Share, 2016-2027
Figure 30. Brazil Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 31. Argentina Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 32. By Country - Middle East & Africa Fibrate Drugs Revenue Market Share, 2016-2027
Figure 33. Turkey Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 34. Israel Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 35. Saudi Arabia Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 36. UAE Fibrate Drugs Revenue, (US$, Mn), 2016-2027
Figure 37. Teva Pharmaceutical Industries Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 38. Pfizer, Inc. Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 39. Mylan N.V. Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 40. Sanofi SA Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 41. Novartis AG Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 42. GlaxoSmithKline plc Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 43. Sun Pharmaceutical Industries, Inc. Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 44. Macleods Pharmaceuticals Limited Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 45. Aurobindo Pharma Fibrate Drugs Revenue Year Over Year Growth (US$, Mn) & (2016-2021)


More Publications